Nuclear Medicine
Preclinical SPECT/MR Molecular Imaging System Reduces Radiation Dose
A new SPECT/MR hybrid molecular imaging system has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, cost-effective technologic innovation, and reduced exposure to ionizing radiation. More...26 Jun 2013
PET Detects Increased Cognitive Reserve Levels in Very Educated Pre-Alzheimer’s Patients
Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer’s disease better deal with the disease than individuals with a lower level of education in the same setting. More...18 Jun 2013
In Other News
Prostate Cancer Patient Receives First Treatment of Real-Time Brachytherapy Planning System
Boron Radiotherapy May Cure Human Cancers
Stroke Risk Assessment Helps Identify Cognitive Decline Early
Future Breast Cancer Screening Will Need Personalized Approach
Nuclear Medicine Enables Earlier COPD Diagnosis
New Imaging Agent Provides Better Cancer Diagnosis with More Effective Staging
Surgery Bests Radiotherapy for Localized Prostate Cancer
Potential in MRI and PET-CT Lymphoma Cancer Characterization
First Imaging Agent Approved for Visualization of Myocardial Sympathetic Innervation in Specific Heart Failure Patients
Cutting-Edge Head and Neck Imaging Optimizes Healthcare in Clinical Practice
Alzheimer’s Risk Gene Identified Using Connectome Scan
PET or PET/CT Benefits in Bone, Soft Tissue Tumors Not Validated
Highly Sensitive Prostate Cancer Imaging Using Small Prostate-Specific Membrane Antigen Molecules
First Global Commercial Hybrid SPECT/CT System Installed at US Hospital
Hepatic Function SPECT Testing Before and During Radiotherapy Can Help in Treatment Planning for Liver Cancer Patients
Imaging for Amyloid Deposits Also Shows Promise for Detecting Cardiac Amyloidosis
Gold Nanoparticles to Deliver Powerful Radioactive Particles Directly to Tumors for Treatment
First Guidelines Released for Brain Amyloid Imaging in Alzheimer’s Disease Patients
Applications Designed to Generate Isotopes for the Development of New Radiopharmaceuticals for Cancer Treatment
Outsourced Radiologists Perform Better Readings for Fewer Hospitals
PET/CT Better Than Traditional Staging for Locally Advanced Breast Cancer Patients
Benefits of PET or PET/CT Imaging Unproven in Recurrent Bowel Cancer
Radiopharmaceuticals Can More Effectively Manage Treatment and Predict Survival for Patients with Gliomas
The Nuclear Medicine channel of MedImaging brings the latest in research and clinical radiotherapy, proton therapy, PET-CT, SPECT, SQUID, radiopharmacology, scintillography, trends and safety concerns.